Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548128 · ClinicalTrials.gov registry record
Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 102
- Enrollment target
NCT04548128 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 102 participants.
The verdict
NCT04548128 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3 utilizing techniques other than full median sternotomy (e.g. thoracotomy) and impact on post-implant length of stay.
Interventions
- DEVICE HeartMate 3 Left Ventricular Assist System (HM3 LVAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-11-17 |
| Est. Completion | 2022-12-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04548128
The ClinicalTrials.gov registry entry for NCT04548128 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HeartMate 3 Left Ventricular Assist System (HM3 LVAS) is the first listed.
NCT04548128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04548128 about?
NCT04548128 is a clinical study titled "Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS". This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3 utilizing techniques other than full median sternotomy (e.g. thoracotomy) and impact on pos...
What is the current status of trial NCT04548128?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2020-11-17. Estimated completion is 2022-12-20.
What interventions are being tested in trial NCT04548128?
The interventions under investigation include: HeartMate 3 Left Ventricular Assist System (HM3 LVAS) (DEVICE).
Who is sponsoring clinical trial NCT04548128?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.